Uterine Lavage for Ovarian Cancer Risk Detection

This trial seeks a new method to detect ovarian cancer early in women with BRCA gene mutations, who face a higher risk of developing this cancer. The procedure, called uterine lavage, rinses and collects cells from the fallopian tube for analysis. The trial seeks women with BRCA1 or BRCA2 mutations who still have their uterus and at least one fallopian tube and are planning risk-reduction surgery. The goal is to determine if this method can identify genetic changes that might lead to cancer. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research in early cancer detection.

Research has shown that uterine lavage, which uses a saltwater solution to rinse and collect cells from the fallopian tube, is safe. In a study with 93 participants, nearly all procedures succeeded, and most patients found the process easy. The study also found that uterine lavage gathered enough cells for analysis in every patient, crucial for cancer detection. Importantly, no major side effects or safety issues were reported, indicating that the procedure is well-tolerated. This makes uterine lavage a promising non-surgical option for ovarian cancer screening in high-risk patients.¹²³⁴⁵

Researchers are excited about uterine lavage for ovarian cancer risk detection because it offers a non-invasive approach to potentially identifying cancer risk earlier than current methods, which often rely on imaging and blood tests. This technique involves washing the uterus and analyzing the fluid for molecular markers that could indicate the presence or risk of ovarian cancer. Unlike standard procedures, uterine lavage could provide a more direct and localized assessment of risk, helping to identify individuals who may benefit from early intervention.

Research has shown that uterine lavage, a procedure involving the rinsing and collection of cells from the fallopian tube, might help detect early signs of ovarian cancer in women with BRCA1 or BRCA2 gene mutations. These mutations significantly increase the risk of ovarian cancer. In this trial, participants will undergo uterine lavage before their standard risk-reduction surgery, and researchers will perform molecular analysis on the collected samples. Although direct evidence on the effectiveness of uterine lavage for this purpose remains limited, the goal is to identify genetic changes in cells that could signal the onset of cancer. This early detection method aims to identify potential cancer development early, which is crucial for those at high risk. Initial findings suggest that studying these cells might provide valuable information about cancer risk.⁶⁷⁸⁹¹⁰